keyword
https://read.qxmd.com/read/38336897/consensus-guideline-for-the-diagnosis-and-management-of-pituitary-adenomas-in-childhood-and-adolescence-part%C3%A2-1-general-recommendations
#41
REVIEW
Márta Korbonits, Joanne C Blair, Anna Boguslawska, John Ayuk, Justin H Davies, Maralyn R Druce, Jane Evanson, Daniel Flanagan, Nigel Glynn, Claire E Higham, Thomas S Jacques, Saurabh Sinha, Ian Simmons, Nicky Thorp, Francesca M Swords, Helen L Storr, Helen A Spoudeas
Tumours of the anterior part of the pituitary gland represent just 1% of all childhood (aged <15 years) intracranial neoplasms, yet they can confer high morbidity and little evidence and guidance is in place for their management. Between 2014 and 2022, a multidisciplinary expert group systematically developed the first comprehensive clinical practice consensus guideline for children and young people under the age 19 years (hereafter referred to as CYP) presenting with a suspected pituitary adenoma to inform specialist care and improve health outcomes...
February 9, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38319368/the-role-of-preoperative-mri-in-endoscopic-transnasal-transsphenoidal-hypophysectomy-of-pituitary-adenoma
#42
JOURNAL ARTICLE
Muaid I Aziz Baban, Shkar N Omer, Abeer K Abbas AlZuhairy, Abbas A Mahmoud
BACKGROUND: The trans-sphenoidal approach, commonly used for removing pituitary adenomas, has become a widely accepted and successful method. In recent years, the endoscopic trans-sphenoidal technique has emerged as a minimally invasive surgical approach for pituitary adenoma removal. The majority of pituitary adenomas exhibit a soft consistency and can be successfully extracted with aspiration and curettage using the trans-sphenoidal approach. However, a subset of around 5-15% of these adenomas possess a solid and fibrous texture...
February 6, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38318883/surgical-and-non-surgical-interventions-for-primary-and-salvage-treatment-of-growth-hormone-secreting-pituitary-adenomas-in-adults
#43
REVIEW
Lisa Caulley, Jason G Quinn, Mary-Anne Doyle, Fahad Alkherayf, Maria-Inti Metzendorf, Shaun Kilty, M G Myriam Hunink
BACKGROUND: Growth hormone (GH)-secreting pituitary adenoma is a severe endocrine disease. Surgery is the currently recommended primary therapy for patients with GH-secreting tumours. However, non-surgical therapy (pharmacological therapy and radiation therapy) may be performed as primary therapy or may improve surgical outcomes. OBJECTIVES: To assess the effects of surgical and non-surgical interventions for primary and salvage treatment of GH-secreting pituitary adenomas in adults...
February 6, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38304798/functional-gonadotroph-pituitary-adenoma-a-case-report
#44
Wenzhen Yang, Jing Zheng, Hu Yang, Qiang Li, Xiaoqiang Wang, Yinliang Bai, Shuting Yang, Jie Liu
Most clinically non-functioning pituitary tumour arise from gonadotroph cells. However, clinically functional pituitary gonadotroph adenoma is rare. Here we report a female case who presented with menstrual disturbances, however further workup demonstrated a pituitary microadenoma with elevated FSH and oestradiol level. Transsphenoidal resection was performed and the surgical histopathology confirmed pituitary gonadotroph adenoma. Postoperatively, improvement in both symptoms and hormonal profile were observed...
January 30, 2024: Heliyon
https://read.qxmd.com/read/38290212/primary-pituitary-tuberculoma-with-a-pituitary-apoplexy-like-presentation
#45
JOURNAL ARTICLE
Gaayathri Krishnan, Nur Hidayah Mohd Makhatar, Tee Hwee Ching, Serena Khoo
SUMMARY: Pituitary tuberculoma is extremely rare and may pose as a diagnostic challenge especially when encountered as an isolated lesion without other systemic manifestation of tuberculosis. A 21-year-old female was admitted for diabetic ketoacidosis. On the third day of admission following the resolution of diabetic ketoacidosis she developed a sudden onset of headache and blurring of vision suggestive of pituitary apoplexy. An urgent MRI brain revealed a large sellar mass with erosion into the sphenoid sinus and intracranial vasculitis...
January 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38261442/stereotactic-radiosurgery-in-india-a-nationwide-survey-of-technology-and-quality-assurance-practices
#46
JOURNAL ARTICLE
Parimal T Patwe, Sudesh Deshpande, Suresh Chaudhari, Gajanan R Mahajan
PURPOSE: India is rapidly adopting advanced treatments like Stereotactic Radiosurgery (SRS). However, there is a paucity of data on SRS practice. The aim of study is to assess the current status of technology and practices of machine quality assurance (QA) and patient specific quality assurance for SRS in India. MATERIALS AND METHODS: A survey questionnaire was designed using Google Forms and sent to chief/senior medical physicists across 220 radiotherapy centers in India on July 15, 2022...
January 22, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38235757/immunotherapy-for-endocrine-tumours-a-clinician-s-perspective
#47
REVIEW
Anna Angelousi, Ploutarchos Tzoulis, Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Gregory Kaltsas
Immunotherapy has revolutionised the treatment of oncological patients, but its application in various endocrine tumours is rather limited and is mainly used when conventional therapies have failed. Immune checkpoint inhibitors (ICIs) have been employed in progressive adrenocortical carcinoma, primarily utilizing the anti-PD-L1 agent pembrolizumab, obtaining overall response rates ranging between 14% and 23%. In contrast, the response rate in phaeochromocytoma/paraganglioma was substantially less at 9%, considering the small number of patients treated...
April 1, 2024: Endocrine-related Cancer
https://read.qxmd.com/read/38231133/efficacy-of-cabergoline-in-non-irradiated-patients-with-acromegaly-a-multi-centre-cohort-study
#48
JOURNAL ARTICLE
Sandrine A Urwyler, Irene Samperi, Kirstie Lithgow, Akash Mavilakandy, Mike Matheou, Karin Bradley, Aparna Pal, Narendra L Reddy, John Ay, Niki Karavitaki
OBJECTIVE: Elucidate the efficacy (as per current biochemical criteria) of cabergoline monotherapy or as addition to long-acting somatostatin receptor ligand (SRL) in patients with acromegaly and no previous pituitary radiotherapy. DESIGN: Multi-centre, retrospective, cohort study (four UK Pituitary centres: Birmingham, Bristol, Leicester, Oxford). METHODS: Clinical, laboratory, imaging data were analysed. RESULTS: Sixty-nine patients on cabergoline monotherapy were included [median IGF-1 xUpper Limit of Normal (ULN) pre-cabergoline 2...
January 17, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38187082/prognostic-biomarkers-in-pituitary-tumours-a-systematic-review
#49
REVIEW
Eirini Papadimitriou, Eleftherios Chatzellis, Anastasia Dimitriadi, Gregory A Kaltsas, Stamatios Theocharis, Krystallenia I Alexandraki
Pituitary tumours (PTs) are the second most common intracranial tumour. Although the majority show benign behaviour, they may exert aggressive behaviour and can be resistant to treatment. The aim of this review is to report the recently identified biomarkers that might have possible prognostic value. Studies evaluating potentially prognostic biomarkers or a therapeutic target in invasive/recurrent PTs compared with either non-invasive or non-recurrent PTs or normal pituitaries are included in this review. In the 28 included studies, more than 911 PTs were evaluated...
November 2023: TouchREVIEWS in endocrinology
https://read.qxmd.com/read/38179430/enhanced-epr-effects-by-tumour-stromal-cell-mimicking-nanoplatform-on-invasive-pituitary-adenoma
#50
JOURNAL ARTICLE
Junning Ma, Yin Wei, Xiaojian Zhang, Lu Lin, Youmei Bao, Hui Cao, Honghwei Chen, Jianbo Yu, Jiqi Yang, Yue Zhang, Huimin Lan, XueYang Li, Huang Qiong, Dan Yang, Yajun Yu, Jingyao Chen, Chengchen Zhang, Li Liu, Lei Chen, Renya Zhan, Fei Liu
Rapid advances in nanomedicine have enabled potential applications in cancer therapy. The enhanced permeability and retention (EPR) effect is the primary rationale for the passive targeting of nanoparticles in oncology. However, growing evidence indicates that the accumulation of nanomaterials via the EPR effect could be more efficient. Inspired by our clinical observation of the Gap Junction connecpion between folliculostellate cells and pituitary adenoma cells, we designed a novel drug delivery system that targets tumours by coating folliculostellate cell (FS) membranes onto PLGA nanoparticles (NPs)...
February 2024: Materials today. Bio
https://read.qxmd.com/read/38160655/the-learning-curve-for-endoscopic-endonasal-transsphenoidal-pituitary-surgery-evaluating-endocrine-outcomes
#51
JOURNAL ARTICLE
Nicholas G Candy, Alistair K Jukes, Jorn Van Der Veken, David J Torpy, Nick Vrodos, Stephen Santoreneos, Peter-John Wormald, Alkis J Psaltis
OBJECTIVE: In South Australia endoscopic endonasal approach (EEA) pituitary surgery has been practiced since 2006, largely by two neurosurgeons with a small fellowship-trained otolaryngology team. The aim of this cohort study was to determine if a "learning curve" can be established over this time period, as represented by structural and endocrine patient outcomes. METHOD: Retrospective cohort study of patients undergoing EEA surgery between 2006 and 2021 in Adelaide, South Australia at three tertiary teaching hospitals...
December 30, 2023: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38146042/cognition-and-psychological-wellbeing-in-hypopituitary-patients
#52
REVIEW
Syed Ali Imran, Michael Wilkinson
Hypopituitarism (HP) frequently occurs in patients presenting with sellar masses and despite recent advances in therapeutic options, HP patients consistently suffer from impaired quality of life due to psychological distress and cognitive dysfunction. These neurocognitive complications tend to persist in spite of surgical or biochemical remission of the disease making it especially challenging to segregate the effect of HP per se from other comorbidities such as the effect of tumour, surgery, radiation therapy, or complications caused by excess hormone production...
December 26, 2023: Reviews in Endocrine & Metabolic Disorders
https://read.qxmd.com/read/38143211/a-clinical-perspective-on-ectopic-cushing-s-syndrome
#53
REVIEW
Oskar Ragnarsson, C Christofer Juhlin, David J Torpy, Henrik Falhammar
Cushing's syndrome (CS) refers to the clinical features of prolonged pathological glucocorticoid excess. About 10-20% of individuals with CS have ectopic CS (ECS), that is, an adrenocorticotropin (ACTH)-producing tumour outside the pituitary gland. ACTH-secreting neuroendocrine neoplasia (NENs) can arise from many organs, although bronchial NEN, small cell lung cancer (SCLC), pancreatic NEN, thymic NEN, medullary thyroid cancer (MTC), and pheochromocytoma are the most common. Patients with ECS frequently present with severe hypercortisolism...
December 23, 2023: Trends in Endocrinology and Metabolism: TEM
https://read.qxmd.com/read/38131177/the-correlation-among-claudin-9-tyrosine-kinase-2-and-signal-transducers-and-activators-of%C3%A2-transcription-3-expressions-in-non-functioning-pituitary-adenoma-and-invasiveness
#54
JOURNAL ARTICLE
Abudukadier Yasen, Maimaitiyiming Tuoheti, Ba Tu, Cheng Zhang, Yu Ding, Fey Tang, Yonggang Wu
BACKGROUND: Deeper studies on the pathological mechanism associated with invasiveness of non-functioning pituitary adenoma (NFPA) is imperative to find better treatments. This research was preliminarily conducted to investigate the correlation between the expression of Claudin-9 (CLDN9), Tyrosine kinase-2 (TYK2), Signal transducers and activators of transcription-3 (STAT3) and invasiveness in NFPA to illustrate the pathological mechanism. METHODS: Clinical data and surgical specimens of 12 patients with NFPA were collected and divided into invasive and non-invasive NFPA groups, comprising six patients for each group...
December 12, 2023: Neuro Endocrinology Letters
https://read.qxmd.com/read/38125262/rare-case-of-a-clival-chondroma-resulting-in-panhypopituitarism
#55
Ekrem Yetiskul, Yisroel Y Grabie, Amira Hassan, Fatema Arafa, Salman Khan
Chondromas are rare benign tumors composed of hyaline cartilage that can arise in various locations in the body. Their occurrence in the clivus, leading to panhypopituitarism, is exceptionally rare. This case report describes a 93-year-old female with a known clival chondroma who presented with altered mental status, presumed to be secondary to toxic metabolic encephalopathy due to an infectious cause. Further diagnostic evaluation revealed pituitary hormone levels below the normal range. This case report aims to highlight a unique case of panhypopituitarism attributed to a chondroma in the clivus with tumor extension to the sellar region, emphasizing the diagnostic challenges and treatment options for this unusual pathology...
November 2023: Curēus
https://read.qxmd.com/read/38124114/a-comprehensive-characterisation-of-phaeochromocytoma-and-paraganglioma-tumours-through-histone-protein-profiling-dna-methylation-and-transcriptomic-analysis-genome-wide
#56
JOURNAL ARTICLE
Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Fishbein, Roberta Noberini, Ioannis N Anastopoulos, Nicola Tufton, Eugenie S Lim, Rupert Obholzer, Johnathan G Hubbard, Mufaddal Moonim, Tiziana Bonaldi, Katherine L Nathanson, Louise Izatt, Rebecca J Oakey
BACKGROUND: Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours. Pathogenic variants have been identified in more than 15 susceptibility genes; associated tumours are grouped into three Clusters, reinforced by their transcriptional profiles. Cluster 1A PPGLs have pathogenic variants affecting enzymes of the tricarboxylic acid cycle, including succinate dehydrogenase. Within inherited PPGLs, these are the most common. PPGL tumours are known to undergo epigenetic reprograming, and here, we report on global histone post-translational modifications and DNA methylation levels, alongside clinical phenotypes...
December 20, 2023: Clinical Epigenetics
https://read.qxmd.com/read/38112166/analysis-of-a-pituitary-tumour-with-histological-features-of-central-neurocytoma-points-towards-the-emergence-of-a-new-entity-recognizable-by-a-specific-epigenetic-signature
#57
JOURNAL ARTICLE
Catherine Godfraind, Marie Coutelier, Daniel Pissaloux, Fabien Forest, Fanny Vandenbos, Martin Hasselblatt, Jean Boutonnat, Aurélien Coste, Sylvie Lantuejoul, Anne Mc Leer
No abstract text is available yet for this article.
December 19, 2023: Neuropathology and Applied Neurobiology
https://read.qxmd.com/read/38109442/unveiling-the-neuropathology-tumour-landscape-10-year-statistical-analysis-with-global-comparison-single-centre-experience
#58
JOURNAL ARTICLE
Panche Zdravkovski, Boro Ilievski, Vladimir Rendevski, Aleksandar Chaparoski, Venko Filipce, Aleksandar Zupanoski, Aleksandra Dimovska Gavrilovska, Blagoj Shuntov, Vlado Stolevski, Igor Stojkovski, Menka Lazareska, Ana Mihajlovska Rendevska, Gordana Petrushevska
Introduction : Central nervous system (CNS) tumours represent a significant public health issue worldwide, and their incidence and distribution vary across different populations. Although studies on CNS tumours have been conducted in various countries, there is a lack of information regarding their patterns in Macedonia. Therefore, this study is aimed at investigating the distribution, histopathological types and subtypes and demographic features of CNS tumours in our country. Materials and Methods : A cross sectional study was conducted using the electronic database of the Institute of Pathology - Medical Faculty, University "Ss...
December 1, 2023: Prilozi (Makedonska Akademija Na Naukite i Umetnostite. Oddelenie za Medicinski Nauki)
https://read.qxmd.com/read/38097317/paediatric-cushing-syndrome-a-prospective-multisite-observational-cohort-study
#59
JOURNAL ARTICLE
Christina Tatsi, Crystal Kamilaris, Meg Keil, Lola Saidkhodjaeva, Fabio R Faucz, Prashant Chittiboina, Constantine A Stratakis
BACKGROUND: Paediatric endogenous Cushing syndrome is a rare condition with variable signs and symptoms of presentation. We studied a large cohort of paediatric patients with endogenous Cushing syndrome with the aim of describing anthropometric, clinical, and biochemical characteristics as well as associated complications and outcomes to aid diagnosis, treatment, and management. METHODS: In this prospective, multisite cohort study, we studied children and adolescents (≤18 years at time of presentation) with a diagnosis of Cushing syndrome...
January 2024: Lancet Child & Adolescent Health
https://read.qxmd.com/read/38077701/chemical-meningitis-and-syndrome-of-inappropriate-antidiuretic-hormone-release-siadh-a-rare-presentation-of-pituitary-adenoma-apoplexy
#60
JOURNAL ARTICLE
Nicolas Sandakly, Georgio El Koubayati, Abir Ayoub, Claude Ghorra, Fady G Haddad
UNLABELLED: Pituitary apoplexy is an uncommon condition typically resulting from a sudden haemorrhage within a pituitary adenoma. This bleed can present clinically with a wide array of signs and symptoms. This report documents the case of a 62-year-old male who presented to the Lebanese Hospital Geitaoui University Medical Center with signs and symptoms of meningeal irritation. He was initially thought to have meningitis, and was started on antibiotics; he was then found to have pituitary adenoma apoplexy that was complicated by syndrome of inappropriate antidiuretic hormone release (SIADH)...
2023: European Journal of Case Reports in Internal Medicine
keyword
keyword
88408
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.